Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Accured Expenses (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Change in Accured Expenses data on record, last reported at $2.4 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 35.5% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $9.0 million, up 317.72%, while the annual FY2025 figure was $7.0 million, 143.07% up from the prior year.
  • Change in Accured Expenses reached $2.4 million in Q4 2025 per PBH's latest filing, down from $4.7 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $18.4 million in Q2 2021 and bottomed at -$23.1 million in Q1 2021.
  • Average Change in Accured Expenses over 5 years is -$283250.0, with a median of $830500.0 recorded in 2022.
  • Peak YoY movement for Change in Accured Expenses: surged 379.42% in 2023, then plummeted 453.98% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$9.5 million in 2021, then soared by 84.84% to -$1.4 million in 2022, then soared by 379.42% to $4.0 million in 2023, then fell by 6.37% to $3.8 million in 2024, then plummeted by 35.5% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were $2.4 million in Q4 2025, $4.7 million in Q3 2025, and -$813000.0 in Q2 2025.